Aimee Stablewski

558 total citations
18 papers, 379 citations indexed

About

Aimee Stablewski is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Aimee Stablewski has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in Aimee Stablewski's work include Pluripotent Stem Cells Research (3 papers), CRISPR and Genetic Engineering (3 papers) and Genetic Syndromes and Imprinting (2 papers). Aimee Stablewski is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), CRISPR and Genetic Engineering (3 papers) and Genetic Syndromes and Imprinting (2 papers). Aimee Stablewski collaborates with scholars based in United States, Russia and Poland. Aimee Stablewski's co-authors include Michael J. Higgins, Carter J. Barger, Adam R. Karpf, Kunle Odunsi, Victor V. Lobanenkov, Dmitri Loukinov, Wa Zhang, Barbara C. Vanderhyden, Herry Herman and Paul D. Soloway and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Aimee Stablewski

17 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimee Stablewski United States 12 300 98 51 39 36 18 379
Rachel Kalifa Israel 8 224 0.7× 80 0.8× 104 2.0× 47 1.2× 40 1.1× 12 343
Barry L. Barnoski United States 10 422 1.4× 132 1.3× 45 0.9× 22 0.6× 44 1.2× 16 568
Ephrem Chin United States 10 256 0.9× 155 1.6× 25 0.5× 55 1.4× 49 1.4× 16 431
Kuniko Nakajima Japan 12 489 1.6× 150 1.5× 36 0.7× 57 1.5× 28 0.8× 19 580
Peter G. Hendrickson United States 6 578 1.9× 70 0.7× 64 1.3× 27 0.7× 36 1.0× 13 671
Ji Yoo Kim Japan 9 321 1.1× 62 0.6× 37 0.7× 32 0.8× 88 2.4× 13 446
Sandra Salem Canada 8 228 0.8× 87 0.9× 64 1.3× 45 1.2× 107 3.0× 10 420
Sou‐De Cheng Taiwan 11 320 1.1× 164 1.7× 133 2.6× 47 1.2× 27 0.8× 16 494
Yue-Zhong Wu United States 10 416 1.4× 85 0.9× 59 1.2× 73 1.9× 45 1.3× 10 487
Anja Brehm Germany 7 333 1.1× 159 1.6× 33 0.6× 14 0.4× 68 1.9× 9 429

Countries citing papers authored by Aimee Stablewski

Since Specialization
Citations

This map shows the geographic impact of Aimee Stablewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee Stablewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee Stablewski more than expected).

Fields of papers citing papers by Aimee Stablewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee Stablewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee Stablewski. The network helps show where Aimee Stablewski may publish in the future.

Co-authorship network of co-authors of Aimee Stablewski

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee Stablewski. A scholar is included among the top collaborators of Aimee Stablewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee Stablewski. Aimee Stablewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Mohammadpour, Hemn, Minhyung Kim, Spencer R. Rosario, et al.. (2024). Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression. iScience. 27(3). 109187–109187. 2 indexed citations
3.
Rajabian, Nika, Ramkumar Thiyagarajan, Aref Shahini, et al.. (2023). Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle. Nature Communications. 14(1). 886–886. 22 indexed citations
4.
Safina, Alfiya, Katerina I. Leonova, Aimee Stablewski, et al.. (2023). Comparison of cell response to chromatin and DNA damage. Nucleic Acids Research. 51(21). 11836–11855. 5 indexed citations
5.
Sandlesh, Poorva, Aimee Stablewski, Ilya Toshkov, et al.. (2022). FACT maintains nucleosomes during transcription and stem cell viability in adult mice. EMBO Reports. 23(4). e53684–e53684. 9 indexed citations
6.
Xu, Chao, et al.. (2022). MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity. PLoS Genetics. 18(5). e1010171–e1010171. 18 indexed citations
7.
Shahini, Aref, Nika Rajabian, T M Nguyen, et al.. (2021). Ameliorating the hallmarks of cellular senescence in skeletal muscle myogenic progenitors in vitro and in vivo. Science Advances. 7(36). eabe5671–eabe5671. 23 indexed citations
8.
Winkler, M., Prashant Kumar Singh, Eduardo Cortes, et al.. (2021). Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation. Molecular Therapy — Oncolytics. 23. 38–50. 11 indexed citations
9.
Zhang, Boyang, Hanqin Li, Zhixing Hu, et al.. (2021). Generation of mouse–human chimeric embryos. Nature Protocols. 16(8). 3954–3980. 6 indexed citations
10.
Lynch, Brian, et al.. (2020). SERINC5 Potently Restricts Retrovirus Infection In Vivo. mBio. 11(4). 23 indexed citations
11.
Hu, Zhixing, Hanqin Li, Houbo Jiang, et al.. (2020). Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos. Science Advances. 6(20). eaaz0298–eaaz0298. 44 indexed citations
12.
Stablewski, Aimee, et al.. (2020). Improved hematopoietic differentiation of mouse embryonic stem cells through manipulation of the RNA binding protein ARS2.. Stem Cell Research. 43. 101710–101710. 2 indexed citations
13.
Pugacheva, Elena M., Carter J. Barger, Spencer R. Rosario, et al.. (2019). BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14. Molecular Cancer Research. 17(10). 2051–2062. 22 indexed citations
14.
Kelkar, Anju, et al.. (2019). Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing. Molecular Therapy. 28(1). 29–41. 23 indexed citations
15.
Barger, Carter J., Wa Zhang, Aimee Stablewski, et al.. (2015). Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Oncotarget. 6(29). 27613–27627. 59 indexed citations
16.
Bhattacharya, Arup, et al.. (2014). The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage. Oncotarget. 6(2). 836–845. 11 indexed citations
17.
Li, Fengzhi, Qiuying Cheng, Xiang Ling, et al.. (2010). Generation of a Novel Transgenic Mouse Model for Bioluminescent Monitoring of Survivin Gene Activity in Vivo at Various Pathophysiological Processes. American Journal Of Pathology. 176(4). 1629–1638. 17 indexed citations
18.
Herman, Herry, Yoon Jung Park, Anders M. Lindroth, et al.. (2005). Rasgrf1 Imprinting Is Regulated by a CTCF-Dependent Methylation-Sensitive Enhancer Blocker. Molecular and Cellular Biology. 25(24). 11184–11190. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026